ATE187068T1 - MICROGRANULES CONTAINING 5-NITROIMIDAZOLE DERIVATIVES - Google Patents

MICROGRANULES CONTAINING 5-NITROIMIDAZOLE DERIVATIVES

Info

Publication number
ATE187068T1
ATE187068T1 AT95907683T AT95907683T ATE187068T1 AT E187068 T1 ATE187068 T1 AT E187068T1 AT 95907683 T AT95907683 T AT 95907683T AT 95907683 T AT95907683 T AT 95907683T AT E187068 T1 ATE187068 T1 AT E187068T1
Authority
AT
Austria
Prior art keywords
microgranules
medicinal
nitroimidazole derivatives
microgranules containing
hand
Prior art date
Application number
AT95907683T
Other languages
German (de)
Inventor
Gerard Leduc
Patrice Debregeas
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9400394A external-priority patent/FR2715067B1/en
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Application granted granted Critical
Publication of ATE187068T1 publication Critical patent/ATE187068T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Medicinal form contains a combination of microgranules of derivatives 5-nitroimidasole, consisting, on the one hand, of gastro-resistant microgranules and, on the other hand, of microgranules with a prolonged release of a medicinal agent. Gastroresistant microgranules are intended to guarantee the efficiency of the medicinal form of the present invention, primarily, in the upper part of gastrointestinal tract, while the microgranules with a prolonged medicinal agent release are operate mainly in the lower part of gastrointestinal tract.
AT95907683T 1994-01-14 1995-01-12 MICROGRANULES CONTAINING 5-NITROIMIDAZOLE DERIVATIVES ATE187068T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9400394A FR2715067B1 (en) 1994-01-14 1994-01-14 New dosage form of 5-nitro-imidazole derivatives effective for the treatment of parasitic infections and infections of the entire gastrointestinal tract.

Publications (1)

Publication Number Publication Date
ATE187068T1 true ATE187068T1 (en) 1999-12-15

Family

ID=9459066

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95907683T ATE187068T1 (en) 1994-01-14 1995-01-12 MICROGRANULES CONTAINING 5-NITROIMIDAZOLE DERIVATIVES

Country Status (19)

Country Link
JP (1) JPH09507499A (en)
KR (1) KR100320140B1 (en)
CN (1) CN1088357C (en)
AT (1) ATE187068T1 (en)
AU (1) AU705570B2 (en)
BR (1) BR9506507A (en)
CZ (1) CZ286080B6 (en)
DE (1) DE69513632T2 (en)
DK (1) DK0739201T3 (en)
ES (1) ES2139883T3 (en)
MA (1) MA23429A1 (en)
MX (1) MX9602772A (en)
NZ (1) NZ279238A (en)
OA (1) OA10583A (en)
PL (1) PL178424B1 (en)
PT (1) PT739201E (en)
RU (1) RU2152212C1 (en)
SK (1) SK282066B6 (en)
UA (1) UA28031C2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4331930B2 (en) * 2001-10-17 2009-09-16 武田薬品工業株式会社 High content granules of acid labile drugs
RU2220711C1 (en) * 2002-04-24 2004-01-10 Закрытое акционерное общество "Брынцалов-А" Antibacterial and antiprotozoan agent "trihobrol"
JP6487534B2 (en) * 2014-09-05 2019-03-20 シンビオミックス セラピューティクス、エルエルシー Sexidazole for use in the treatment of bacterial vaginitis
EP3721871A1 (en) 2019-04-11 2020-10-14 ADD Advanced Drug Delivery Technologies, Ltd. Method for continuous production of a granulate agent
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346095A (en) * 1978-02-10 1982-08-24 Mercer James B Therapeutic treatment for viral hepatitis infection
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3822095A1 (en) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab NEW MEDICAMENT FORMULATION AND METHOD FOR THE PRODUCTION THEREOF
WO1991017744A1 (en) * 1990-05-14 1991-11-28 Jernberg Gary R Surgical implant and method incorporating chemotherapeutic agents
FR2692146B1 (en) * 1992-06-16 1995-06-02 Ethypharm Sa Stable compositions of gastro-protected omeprazole microgranules and process for obtaining them.

Also Published As

Publication number Publication date
CZ286080B6 (en) 2000-01-12
OA10583A (en) 2002-07-10
CZ205596A3 (en) 1996-10-16
AU1580395A (en) 1995-08-01
UA28031C2 (en) 2000-10-16
DK0739201T3 (en) 2000-05-01
JPH09507499A (en) 1997-07-29
MX9602772A (en) 1997-05-31
AU705570B2 (en) 1999-05-27
CN1138826A (en) 1996-12-25
PL315530A1 (en) 1996-11-12
MA23429A1 (en) 1995-10-01
CN1088357C (en) 2002-07-31
SK282066B6 (en) 2001-10-08
NZ279238A (en) 1998-03-25
KR100320140B1 (en) 2002-07-02
PL178424B1 (en) 2000-04-28
BR9506507A (en) 1997-09-09
SK91496A3 (en) 1996-12-04
DE69513632D1 (en) 2000-01-05
ES2139883T3 (en) 2000-02-16
PT739201E (en) 2000-05-31
RU2152212C1 (en) 2000-07-10
DE69513632T2 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
MX9707334A (en) Pharmaceutical composition containing selected lanthanum carbonate hydrates.
DE69829008D1 (en) Nose, mouth and throat cannula
ID21115A (en) ISOQUUOLOL-3-CARBOXAMIDE CHARACTERIZED, PRODUCTION AND USE AS A MEDICINE
TR199800602A3 (en) Dithiolan derivatives, their preparation and therapeutic effects.
FR15C0024I2 (en) 6-SUBSTITUTED INDOLINONES, THEIR PREPARATION AND THEIR USE AS MEDICINES
NO308854B1 (en) Therapeutic Compounds, Pharmaceutically Acceptable Salts and Formulations Containing the Compounds, and Uses thereof
HUP0200710A3 (en) Benzimidazoles, production thereof and use thereof as medicaments
DE69826684D1 (en) COVALENT-TIED N, O-CARBOXYMETHYLCHITOSAN AND ITS USE
DE60023107D1 (en) PREPARATIONS WITH IMPROVED CONTROLLED RELEASE
BG101401A (en) ORAL COMPOSITIONS WITH OVERALL RELEASE OF CISAPRID
TR200503846T2 (en) Alternative use for modified release insulin sensitiser and use
ES2139883T3 (en) MICROGRANULES OF 5-NITROIMIDAZOLE DERIVATIVES.
EP0672052A1 (en) TACHYQUININ ANTAGONISTS, THEIR PRODUCTION AND THEIR USE IN PHARMACEUTICAL FORMULATIONS.
IT1299197B1 (en) COMPOSITION WITH ANTI-OXIDANT, ANTIPOLIFERATIVE, ENERGETIC ACTIVITY AND SUITABLE TO IMPROVE THE METABOLIC USE OF GLUCOSE.
EE200000207A (en) 8-Azabicyclo [3.2.1] octane-3-methanamine derivatives, their preparation and therapeutic use
ZA973016B (en) Transdermally administered acetylcysteine as mucolytic agent.
EA199900963A1 (en) MEDICAL FORMS OF SERTRALIN IN THE FORM OF A SOLUTION CONCLUDED IN GELATINIC CAPSULES
ZA976619B (en) Benzimidazole derivatives, their preparation and their therapeutic applications.
WO1999020259A3 (en) Compositions containing thiamphenicol and diclofenac
BR9907195A (en) "prolonged-release tiagabine formulations with reduced side effects"
RU2000105740A (en) MEDICINAL FOR POISONING ANIMALS WITH CADMIUM, LEAD AND MERCURY
MY128686A (en) Pharmaceutical composition containing selected lanthanum carbonate hydrates
SK2502U (en) Envelope with delivery note
TR28011A (en) Purified / pure streptogramin and its preparation.
DE69938347D1 (en) MEDICAMENT ADMINISTRATION OF NICOTIN IN THE FORM OF GUM

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee